Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta‑analysis

  • Authors:
    • Yu Fang
    • Zhandong Qiu
    • Wentao Hu
    • Jia Yang
    • Xiyan Yi
    • Liangjiang Huang
    • Suming Zhang
  • View Affiliations

  • Published online on: November 26, 2013     https://doi.org/10.3892/etm.2013.1425
  • Pages: 429-434
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cognitive impairments are observed in numerous patients following coronary bypass surgery, and piracetam are nootropic compounds that modulate cerebral functions by directly enhancing cognitive processes. The present meta-analysis was conducted to evaluate the protective effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery. The relevant studies were identified by searching Medline, EMBASE, PubMed and the Cochrane Library up to June 2013 and the pertinent bibliographies from the retrieved studies were reviewed. Data were selected from the studies according to predefined criteria. The meta‑analysis included two randomized control trials involving 184 patients and including the Syndrom‑Kurz test (SKT). Findings of the meta‑analysis showed that following treatment the change from baseline observed in five SKT subtest scores, conducted with piracetam patients, indicated a significant advantage over those patients that were in the placebo group. The subtests included immediate pictured object recall, weighted mean difference (WMD)=0.91, 95% confidence interval (CI) 0.51‑1.31, P<0.00001; delayed pictured object recall, WMD=0.74, 95% CI 0.19‑1.28, P=0.008; delayed picture recognition, WMD=0.82, 95% CI 0.31‑1.31, P=0.001; immediate word recall, WMD=0.87, 95% CI 0.47‑1.28, P<0.0001; and letter interference, WMD=3.46, 95% CI -5.69 to -1.23, P=0.002. These results indicated that piracetam may have been effective in improving the short‑term cognitive performance of patients undergoing coronary bypass surgery. High quality, well‑controlled and longer randomized trials are required to corroborate this result.

Related Articles

Journal Cover

February 2014
Volume 7 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Fang, Y., Qiu, Z., Hu, W., Yang, J., Yi, X., Huang, L., & Zhang, S. (2014). Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta‑analysis. Experimental and Therapeutic Medicine, 7, 429-434. https://doi.org/10.3892/etm.2013.1425
MLA
Fang, Y., Qiu, Z., Hu, W., Yang, J., Yi, X., Huang, L., Zhang, S."Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta‑analysis". Experimental and Therapeutic Medicine 7.2 (2014): 429-434.
Chicago
Fang, Y., Qiu, Z., Hu, W., Yang, J., Yi, X., Huang, L., Zhang, S."Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta‑analysis". Experimental and Therapeutic Medicine 7, no. 2 (2014): 429-434. https://doi.org/10.3892/etm.2013.1425